IndiaOne Finance - Company Dashboard

Governance Classic Home

Wockhardt LtdPharmaceuticalsINE049B01025Consolidated₹2086.10+13.80 (+0.67%)Jun-26

Valuation

Market Cap₹33.90K Cr

TTM PE82.78x

Forward PE76.73x

PEG0.90

Book Value₹304.01

P/B6.86x

TTM EPS₹25.20

Fwd EPS₹27.19

TTM Revenue₹3.56K Cr

TTM PAT₹414.00 Cr

TTM EBITDA₹772.00 Cr

TTM EBIT₹546.00 Cr

Last Qtr PAT₹107.00 Cr

Last Qtr EBITDA₹192.00 Cr

Last Qtr EBIT₹137.00 Cr

Profitability

ROE8.38%

ROCE9.57%

TTM NPM11.62%

TTM EBITDA %21.66%

Curr OPM11.15%

Last OPM16.24%

Curr NPM—

Last NPM—

Curr EPS₹6.55

Last EPS₹10.23

Balance sheet

Equity₹81.00 Cr

Reserve₹4.86K Cr

Total Debt₹2,163.00 Cr

D/E0.44x

Interest %48.60%

Curr Interest₹52.00 Cr

Price / range

Close₹2086.10

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.67%

1W-4.28%

1M+12.16%

3M+4.87%

6M+71.20%

1Y+36.71%

2Y+118.06%

3Y+761.49%

5Y+373.90%

Diwali+46.72%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	561+35.8%	516	430	380	413	1,739
Other Income	33	55	27	30	25	137
Total Income	594+35.6%	571	457	410	438	1,876
Interest	43	41	50	44	41	176
Expenditure	-487-32.0%	-439	-419	-356	-369	-1,584
PBDT	0	0	0	0	0	0
EBITDA	158+20.6%	161	113	113	131	517
Depreciation	-41	-43	-52	-45	-46	-186
EBIT	117+37.6%	118	61	68	85	331
PBT	107+55.1%	167	28	54	69	317
Tax	0	0	0	0	0	0
Equity	81	81	81	0	81	81
OPM	18.01	29.25	6.13	14.21	15.75	16.90
Net Profit	107+55.1%	167	28	54	69	317
NPM	18.01	29.25	6.13	14.21	15.75	16.90
EPS	6.62+55.8%	10.29	1.73	3.26	4.25	19.54

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,739+24.0%	1,402+21.5%	1,154+7.6%	1,072-21.9%	1,372+39.0%	987.26
Other Income	137	55	41	67	38	40.73
Total Income	1,876+28.8%	1,457+21.9%	1,195+4.9%	1,139-19.2%	1,410+37.2%	1,027.99
Expenditure	-1,584-7.8%	-1,469+8.4%	-1,603-13.1%	-1,417+11.1%	-1,594-5.6%	-1,509.28
Interest	-176	-199	-237	-229	-273	-200.24
PBDT	0	0	0	0	0	0
EBITDA	517+72.3%	300+933.3%	-36-151.4%	70-68.5%	222+261.2%	-137.70
Depreciation	-186	-168	-176	-186	-171	-184.08
EBIT	331+150.8%	132+162.3%	-212-82.8%	-116-327.5%	51+115.8%	-321.78
PBT	317+2741.7%	-12+97.2%	-422+17.7%	-513-178.8%	-184+70.5%	-623.77
Tax	0	0	0	47	44	231.73
Equity	81	81	0	0	0	0
OPM (%)	16.90	-0.82	-35.00	-45.00	-13.00	-61.00
Net Profit	317+2741.7%	-12+97.2%	-422+9.4%	-466-232.9%	-140-123.6%	593.29
NPM (%)	16.90	-0.82	-35.00	-41.00	-10.00	58.00
EPS (Rs)	19.54	0+100.0%	-29.27+9.7%	-32.40-178.8%	-11.62-121.7%	53.57
CEPS	19.52	0	-29.27	-32.40	-11.62	53.34

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	929+25.9%	965	888	782	738	3,373
Other Income	31	45	25	21	20	111
Total Income	960+26.6%	1,010	913	803	758	3,484
Interest	52	50	60	55	48	213
Expenditure	-844-9.6%	-843	-836	-712	-770	-3,161
PBDT	0	0	0	0	0	0
EBITDA	192+166.7%	225	177	178	72	652
Depreciation	-55	-53	-65	-53	-56	-227
EBIT	137+756.3%	172	112	125	16	425
PBT	116+206.4%	189	67	91	-109	238
Tax	-9	-25	-6	-9	1	-39
Equity	81	81	0	0	81	81
OPM	12.08	18.71	7.34	11.33	-14.38	6.83
Net Profit	107+199.1%	164	61	82	-108	199
NPM	11.15	16.24	6.68	10.21	-14.25	5.71
EPS	6.55+218.4%	10.23	3.61	4.81	-5.53	13.12

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	3,373+12.0%	3,012+7.6%	2,798+5.5%	2,651-17.9%	3,230+19.3%	2,708.30
Other Income	111	62	83	122	20	132.27
Total Income	3,484+13.3%	3,074+6.7%	2,881+3.9%	2,773-14.7%	3,250+14.4%	2,840.57
Expenditure	-3,161-2.3%	-3,090+6.0%	-3,287-5.9%	-3,103+10.8%	-3,478-6.5%	-3,266.43
Interest	-213	-254	-305	-302	-299	-249.08
PBDT	0	0	0	0	0	0
EBITDA	652+65.9%	393+907.7%	39-61.4%	101-66.1%	298+572.8%	-63.03
Depreciation	-227	-217	-223	-251	-247	-246.02
EBIT	425+141.5%	176+195.7%	-184-22.7%	-150-394.1%	51+116.5%	-309.05
PBT	238+1587.5%	-16+96.2%	-420+32.7%	-624-51.8%	-411+27.7%	-568.34
Tax	-39	-41	-52	3	132	271.61
Equity	81	81	0	0	0	0
OPM (%)	6.83	-0.52	-14.58	-22.50	-12.65	-20.01
Net Profit	199+449.1%	-57+87.9%	-472+24.0%	-621-122.6%	-279-140.5%	688.60
NPM (%)	5.71	-1.85	-16.38	-22.39	-8.58	24.24
EPS (Rs)	13.12	0+100.0%	-32.05+17.4%	-38.79-91.7%	-20.24-132.7%	61.95
CEPS	13.10	0	-32.05	-38.79	-20.24	61.68

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2017	Interim Dividend	10	17 Nov 2016
2015	Interim Dividend	20	13 Nov 2014
2014	Interim Dividend	5	17 Feb 2014
2014	Interim Dividend	5	07 Nov 2013
2013	Final Dividend	5	22 Aug 2013
2008	Final Dividend	2.5	17 Apr 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split